Skip to main content
logo
Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
3.770
0.00 (0.00%)
Sep 24, 2026, 10:00 AM EDT - Market open

Indaptus Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
502510151247
Market Cap Growth
16230.05%-49.63%-31.58%21.38%-73.92%-
Enterprise Value
491-13-1-165
Last Close Price
3.772.9123.5849.2840.60159.60

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
44.171.622.571.220.501.30
P/TBV Ratio
44.171.622.571.220.501.30

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
--0.020.010.000.01
Net Debt / Equity Ratio
-1.02-2.70-1.45-1.09-1.07-1.08
Net Debt / EBITDA Ratio
-0.430.370.811.775.04
Net Debt / FCF Ratio
0.790.570.460.982.023.45
Quick Ratio
18.771.381.714.827.708.50
Current Ratio
19.481.511.955.057.948.77
Return on Equity (ROE)
-318.04%-587.59%-187.53%-84.04%-47.32%-43.25%
Return on Assets (ROA)
-98.08%-148.91%-86.28%-47.63%-27.15%-22.81%
Return on Capital Employed (ROCE)
-129.90%-629.30%-389.50%-134.80%-60.50%-21.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-3.07%-409.13%-148.48%-104.31%-117.58%-16.51%
FCF Yield
-2.93%-290.89%-121.81%-90.66%-107.36%-24.18%
Buyback Yield / Dilution
-7142.37%-189.14%-11.36%-1.68%-101.98%-110.35%
SEC Filings: 10-K · 10-Q